On February 27, the Food and Drug Administration (FDA) granted emergency use authorization for Johnson & Johnson’s COVID-19 vaccine for people ages 18 and older. No one in the vaccine group was hospitalized with COVD-19 after 28 days post-vaccination versus 16 in the placebo group. No COVID-19 deaths occurred in the vaccine group while seven were reported in the placebo group. Six people in the vaccine group, but none in the placebo group, reported tinnitus (ringing in the ears); this remains under investigation. Fifteen people in the vaccine group and 10 in the placebo group developed blood clots, and the FDA recommended ongoing monitoring.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.